MESANGIAL CELL APOPTOSIS - THE MAJOR MECHANISM FOR RESOLUTION OF GLOMERULAR HYPERCELLULARITY IN EXPERIMENTAL MESANGIAL PROLIFERATIVE NEPHRITIS

被引:403
作者
BAKER, AJ
MOONEY, A
HUGHES, J
LOMBARDI, D
JOHNSON, RJ
SAVILL, J
机构
[1] UNIV NOTTINGHAM HOSP, DEPT MED, DIV RENAL & INFLAMMATORY DIS, NOTTINGHAM NG7 2UH, ENGLAND
[2] HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH, DEPT MED, RENAL UNIT, LONDON W12 0NN, ENGLAND
[3] UNIV WASHINGTON, DEPT MED, DIV NEPHROL, SEATTLE, WA 98195 USA
基金
英国惠康基金;
关键词
MESANGIAL CELL; APOPTOSIS; GLOMERULONEPHRITIS; RESOLUTION; INJURY;
D O I
10.1172/JCI117565
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Increases in mesangial cell number may herald glomerular scarring, but they are not irreversible. This study sought mechanisms by which surplus glomerular mesangial cells can be cleared. A small proportion of cultured mesangial cells exhibited typical morphological features of apoptosis (programmed cell death), which was increased by growth factor deprivation or exposure to cycloheximide, stimuli known to increase apoptosis in other cell types. Apoptosis was confirmed by typical internucleosomal chromatin cleavage. In vivo, clear morphological evidence of mesangial apoptosis leading to phagocytosis by neighboring mesangial cells was obtained in self-limited mesangial proliferation induced in rats by Thy1.1 antibody, apoptosis occurring similar to 10-fold more frequently than in the healthy rat glomerulus. Indeed, changes in glomerular cell number in Thy1.1 nephritis strongly suggested that apoptosis is the major cell clearance mechanism counterbalancing cell division, thereby mediating resolution of glomerular hypercellularity in experimental mesangial proliferation.
引用
收藏
页码:2105 / 2116
页数:12
相关论文
共 53 条
[1]   INTERLEUKIN-1-BETA STIMULATES HUMAN MESANGIAL CELLS TO SYNTHESIZE AND RELEASE INTERLEUKIN-6 AND INTERLEUKIN-8 [J].
ABBOTT, F ;
RYAN, JJ ;
CESKA, M ;
MATSUSHIMA, K ;
SARRAF, CE ;
REES, AJ .
KIDNEY INTERNATIONAL, 1991, 40 (04) :597-605
[2]   GROWTH-FACTORS IN GLOMERULONEPHRITIS [J].
ABBOUD, HE ;
SCHENA, FP ;
COHEN, JJ ;
STERZEL, RB ;
STRIKER, G ;
GESUALDO, L ;
FINE, LG ;
STRIKER, L ;
PETEN, E ;
THOMSON, N ;
CAMERON, S ;
BORSATTI, A ;
RUBINKELLY, VE ;
REMUZZI, G .
KIDNEY INTERNATIONAL, 1993, 43 (01) :252-267
[3]  
ALBERTS B, 1983, MOL BIOL CELL, P611
[4]   ENHANCED EXPRESSION OF MUSCLE-SPECIFIC ACTIN IN GLOMERULONEPHRITIS [J].
ALPERS, CE ;
HUDKINS, KL ;
GOWN, AM ;
JOHNSON, RJ .
KIDNEY INTERNATIONAL, 1992, 41 (05) :1134-1142
[5]  
ARENDS MJ, 1990, AM J PATHOL, V136, P593
[6]  
AVERS CJ, 1976, MITOSIS MEIOSIS, P449
[7]  
BAGCHUS WM, 1986, LAB INVEST, V55, P680
[8]   CELL-DEATH AND CONTROL OF CELL-SURVIVAL IN THE OLIGODENDROCYTE LINEAGE [J].
BARRES, BA ;
HART, IK ;
COLES, HSR ;
BURNE, JF ;
VOYYODIC, JT ;
RICHARDSON, WD ;
RAFF, MC .
CELL, 1992, 70 (01) :31-46
[9]   TRANSFORMING GROWTH-FACTOR-BETA IN DISEASE - THE DARK SIDE OF TISSUE-REPAIR [J].
BORDER, WA ;
RUOSLAHTI, E .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) :1-7
[10]   SUPPRESSION OF EXPERIMENTAL GLOMERULONEPHRITIS BY ANTISERUM AGAINST TRANSFORMING GROWTH FACTOR-BETA-1 [J].
BORDER, WA ;
OKUDA, S ;
LANGUINO, LR ;
SPORN, MB ;
RUOSLAHTI, E .
NATURE, 1990, 346 (6282) :371-374